Intravenous vitamins and minerals for fibromyalgia.
|Article Type:||Brief article|
(Care and treatment)
Minerals in nutrition (Health aspects)
Minerals in nutrition (Research)
Minerals in the body (Health aspects)
Minerals in the body (Research)
Vitamins (Health aspects)
|Author:||Gaby, Alan R.|
|Publication:||Name: Townsend Letter Publisher: The Townsend Letter Group Audience: General; Professional Format: Magazine/Journal Subject: Health Copyright: COPYRIGHT 2008 The Townsend Letter Group ISSN: 1940-5464|
|Issue:||Date: Feb-March, 2008 Source Issue: 295-296|
|Topic:||Event Code: 310 Science & research|
|Product:||Product Code: 2834710 Vitamin Preparations; 2834700 Vitamin, Nutrient & Hematinic Preps NAICS Code: 325412 Pharmaceutical Preparation Manufacturing SIC Code: 2834 Pharmaceutical preparations|
|Geographic:||Geographic Scope: United States Geographic Code: 1USA United States|
Seven patients with treatment-resistant fibromyalgia, with disease
duration of at least eight years, received an intravenous infusion of
nutrients once a week for eight weeks. Each infusion contained 400 mg of
magnesium chloride hexahydrate, 40 mg of calcium gluconate, 3,000 mg of
vitamin C, 1,000 mcg of hydroxocobalamin, 100 mg of pyridoxine
hydrochloride, 250 mg of dexpanthenol, 2 mg of riboflavin, 100 mg of
thiamine, and 100 mg of niacinamide. The nutrients were administered in
100 ml of normal saline over a period of 20-30 minutes. All patients
reported an improvement in pain and fatigue by the second treatment. At
the end of the treatment period, there was a 60% reduction in the mean
pain severity (p = 0.005) and an 80% decrease in the mean level of
fatigue (p = 0.005). No patient reported complete or lasting resolution
of pain or fatigue. No side effects were reported.
Comment: In my experience with approximately 30 fibromyalgia patients given a treatment similar to the one described above, some (perhaps 25%) became pain-free (Gaby AR. Altern Med Rev. 2002;7:389-403.). Most of my patients received more magnesium chloride hexahydrate (800 mg vs. 400 mg) and calcium gluconate (200 mg [2 ml of a 10% solution] vs. 40 mg) in their infusion than did those in the present study. In addition, the usual infusion rate for my patients was five to 15 minutes, depending on their tolerance. In contrast, the patients in the present study received the infusion over 20-30 minutes. While there are risks associated with too-rapid infusion of magnesium and other nutrients, the higher peak serum nutrient concentrations that occur with more rapid administration may result in enhanced cellular nutrient uptake and a greater therapeutic effect in some cases.
Massey PB. Reduction of fibromyalgia symptoms through intravenous nutrient therapy: results of a pilot clinical trial. Altern Ther Health Med. 2007;13(3):32-34.
|Gale Copyright:||Copyright 2008 Gale, Cengage Learning. All rights reserved.|